Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers

被引：0
|
作者：
Merica, VarshaIyer Elizabeth
Ronseaux, Sebastien
Gamache, Tressa
Mulrow, Nancy J.
Belcijan, Anja
Callaghan, Michael U.
机构：
[1] Agios Pharmaceut Inc, Cambridge, MA USA
[2] Merica Clin Consulting, Boston, MA USA
[3] Mulrow & Associates Consulting LLC, Boston, MA USA
[4] PPD Pharmaceut, Barcelona, Spain
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148381
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2043
引用
收藏
页数：5
相关论文
共 50 条
  • [31] A first in human, single ascending dose study to assess the safety and tolerability, pharmacokinetics, and pharmacodynamics of AB101 in subjects with type 1 diabetes
    Roberts, B. K.
    Wang, X.
    Franey, B.
    Hernandez, M.
    Hompesch, M.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 73 - 73
  • [32] A phase 1 single ascending dose study of the safety, tolerability and pharmacokinetics of CRV431
    Armas, Danielle
    Snyder, Michael
    Trepanier, Daniel
    Ure, Daren
    Greytok, Jill
    Foster, Robert
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E464 - E465
  • [33] A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161 in Chinese healthy volunteers
    Yap, D.
    Zhou, X.
    Chen, X.
    Lee, M.
    Zhang, Y.
    Wang, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1178 - 1179
  • [34] Single Dose Safety, Tolerability, and Pharmacokinetics of AB-423 in Healthy Volunteers from the ongoing Single and Multiple Ascending Dose Study AB-423-001
    Eley, Timothy
    Caamano, Sofia
    Denning, Jill
    Sims, Karen
    Larouche, Richard
    Symonds, William
    Mendez, Patricia
    HEPATOLOGY, 2017, 66 : 490A - 490A
  • [35] A phase I single-rising dose study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of an oral akt inhibitor in healthy male volunteers
    Trucksis, Michele
    Friedman, Evan
    Taylor, Adekemi
    Delgado, Liliana
    Reynders, Tom
    DeSmet, Marina
    Dong, Yingwen
    Fu, Irong
    DeMeyer, Igance
    Chodakewitz, Jeffrey
    Iwamoto, Marian
    Wagner, John
    CANCER RESEARCH, 2009, 69
  • [36] PHASE 1 MULTIPLE ASCENDING DOSE STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS/PHARMACODYNAMICS OF AG-348, A FIRST-IN-CLASS ALLOSTERIC ACTIVATOR OF PYRUVATE KINASE-R, IN HEALTHY SUBJECTS
    Yang, H.
    Merica, E.
    Chen, Y.
    Cohen, M.
    Goldwater, R.
    Kim, H.
    Kosinski, P.
    Kung, C.
    Goldwasser, M.
    Silver, B.
    Utley, L.
    Agresta, S.
    HAEMATOLOGICA, 2015, 100 : 18 - 18
  • [37] A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects
    Hussaini, Azra
    Mukherjee, Rajat
    Berdieva, Dina M.
    Glogowski, Christen
    Mountfield, Richard
    Ho, Peter T. C.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (02): : 337 - 344
  • [38] Single-dose pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase stimulator BAY 63-2521:: An ascending-dose study in healthy male volunteers
    Frey, Reiner
    Mueck, Wolfgang
    Unger, Sigrun
    Artmeier-Brandt, Ulrike
    Weimann, Gerrit
    Wensing, Georg
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (08): : 926 - 934
  • [39] Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
    Peterschmitt, M. Judith
    Crawford, Nigel P. S.
    Gaemers, Sebastiaan J. M.
    Ji, Allena J.
    Sharma, Jyoti
    Pham, Theresa T.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (01): : 86 - 98
  • [40] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Losmapimod in Healthy Japanese Volunteers
    Ino, Hiroko
    Takahashi, Naoki
    Terao, Takumi
    Igarashi, Harue
    Sarai, Nobuaki
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (04): : 262 - 269
12345